期刊文献+

Histopathology of type C liver disease for determining hepatocellular carcinoma risk factors 被引量:3

Histopathology of type C liver disease for determining hepatocellular carcinoma risk factors
下载PDF
导出
摘要 AIM:To evaluate the histopathological findings of type C liver disease to determine risk factors for development of hepatocellular carcinoma(HCC).METHODS:We studied 232 patients,who underwent liver biopsy for type C chronic liver disease between 1992 and 2009,with sustained virological response(SVR)after interferon therapy.The patients were divided into two groups according to the F stage 0+1+2 group(n = 182)and F3+4 group(n = 50).We prospectively observed and compared the incidence of HCC of the patients with SVR in the F0+1+2 and F3+4 groups.Then,the background factors and liver histopathological findings,including the degree of fibrosis,F stage,inflammation,necrosis,bile duct obstruction,fat deposition,and degree of irregular regeneration(IR)of hepatocytes,were correlated with the risk of developing HCC.RESULTS:HCC developed in three of 182(1.6%)patients in the F0+1+2 group,and four of 50(8.0%)in the F3+4 group.The cumulative incidence of HCC in the former group was found to be significantly lower than in the F3+4 group(log rank test P = 0.0224).The presence of atypical hepatocytes among IR of hepatocytes in the F3+4 group resulted in a higher cumulative incidence of HCC,and was significantly correlated with risk of HCC development(RR = 20.748,95%CI:1.335-322.5,P = 0.0303).CONCLUSION:Atypical hepatocytes among the histopathological findings of type C liver disease may be an important risk factor for HCC development along with progression of liver fibrosis. AIM: To evaluate the histopathological findings of type C liver disease to determine risk factors for development of hepatocellular carcinoma (HCC). METHODS: We studied 232 patients, who underwent liver biopsy for type C chronic liver disease between 1992 and 2009, with sustained virological response (SVR) after interferon therapy. The patients were divided into two groups according to the F stage 0 + 1 + 2 group (n = 182) and F3 + 4 group (n = 50). We prospectively observed and compared the incidence of HCC of the patients with SVR in the F0 + 1 + 2 and F3 + 4 groups. Then, the background factors and liver histopathological findings, including the degree of fibrosis, F stage, inflammation, necrosis, bile duct obstruction, fat deposition, and degree of irregular regeneration (IR) of hepatocytes, were correlated with the risk of developing HCC. RESULTS: HCC developed in three of 182 (1.6%) patients in the F0 + 1 + 2 group, and four of 50 (8.0%) in the F3 + 4 group. The cumulative incidence of HCC in the former group was found to be significantly lower than in the F3 + 4 group (log rank test P = 0.0224). The presence of atypical hepatocytes among IR of hepatocytes in the F3 + 4 group resulted in a higher cumulative incidence of HCC, and was significantly correlated with risk of HCC development (RR = 20.748, 95%CI: 1.335-322.5, P = 0.0303). CONCLUSION: Atypical hepatocytes among the histopathological findings of type C liver disease may be an important risk factor for HCC development along with progression of liver fibrosis.
出处 《World Journal of Gastroenterology》 SCIE CAS 2013年第30期4887-4896,共10页 世界胃肠病学杂志(英文版)
关键词 Hepatocellular carcinoma Irregular regeneration of HEPATOCYTES LIVER FIBROSIS TYPE C chronic LIVER disease HISTOPATHOLOGY of LIVER BIOPSY Hepatocellular carcinoma Irregular regeneration of hepatocytes Liver fibrosis Type C chronic liver disease Histopathology of liver biopsy
  • 相关文献

参考文献12

  • 1Ya-Jun Tan.Hepatitis B virus infection and the risk of hepatocellular carcinoma[J].World Journal of Gastroenterology,2011,17(44):4853-4857. 被引量:25
  • 2Katsutoshi Tokushige,Etsuko Hashimoto,Satoru Yatsuji,Maki Tobari,Makiko Taniai,Nobuyuki Torii,Keiko Shiratori.Prospective study of hepatocellular carcinoma in nonalcoholic steatohepatitis in comparison with hepatocellular carcinoma caused by chronic hepatitis C[J].Journal of Gastroenterology.2010(9)
  • 3Poynard T,Bedossa P,Opolon P.Natural history of liver fibrosis progression in patients with chronic hepatitis C.The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups[].The Lancet.1997
  • 4Fattovich G,Stroffolini T,Zagni I,et al.Hepatocellular carcinoma in cirrhosis: incidence and risk factors[].Gastroenterology.2004
  • 5Kiyosawa K,Umemura T,Ichijo T,et al.Hepatocellular carcinoma: recent trends in Japan[].Gastroenterology.2004
  • 6Matteoni CA,Younossi ZM,Gramlich T,et al.Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity[].Gastroenterology.1999
  • 7Desmet VJ,Gerber M,Hoofnagle JH,et al.Classification of chronic hepatitis: diagnosis, grading and staging[].Hepatology.1994
  • 8Knodell R G,Ishak K G,Black W C,et al.Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis[].Hepatology.1981
  • 9Ishak K,Baptista A,Bianchi L,et al.Histological grading and staging of chronic hepatitis[].Journal of Hepatology.1995
  • 10Brunt EM.Nonalcoholic steatohepatitis: definition and pathology[].Seminars in Liver Disease.2001

二级参考文献41

  • 1Dong Q,Chan HL,Liu Z,Chan DP,Zhang B,Chen Y,Kung HF,Sung JJ,He ML. A1762T/G1764A mutations of hepatitis B virus,associated with the increased risk of hepatocellular carcinoma,reduce basal core promoter activities. Biochem Biophys Res Commun 2008; 374: 773-776.
  • 2Kusakabe A,Tanaka Y,Inoue M,Kurbanov F,Tatematsu K, Nojiri S,Joh T,Tsugane S,Mizokami M. A population-based cohort study for the risk factors of HCC among hepatitis B virus mono-infected subjects in Japan. J Gastroenterol 2011; 46: 117-124.
  • 3Tanaka Y,Mukaide M,Orito E,Yuen MF,Ito K,Kurbanov F,Sugauchi F,Asahina Y,Izumi N,Kato M,Lai CL,Ueda R,Mizokami M. Specific mutations in enhancer II/core promoter of hepatitis B virus subgenotypes C1/C2 increase the risk of hepatocellular carcinoma. J Hepatol 2006; 45: 646-653.
  • 4Xu L,Qian G,Tang L,Su J,Wang JS. Genetic variations of hepatitis B virus and serum aflatoxin-lysine adduct on high risk of hepatocellular carcinoma in Southern Guangxi,China. J Hepatol 2010; 53: 671-676.
  • 5Fan W,Shi B,Wei H,Du G,Song S. Comparison of hepatitis B X gene mutation between patients with hepatocellular carcinoma and patients with chronic hepatitis B. Virus Genes 2011; 42: 162-170.
  • 6Chu CM,Liaw YF. Genotype C hepatitis B virus infection is associated with a higher risk of reactivation of hepatitis B and progression to cirrhosis than genotype B: a longitudinal study of hepatitis B e antigen-positive patients with normal aminotransferase levels at baseline. J Hepatol 2005; 43: 411-417.
  • 7Fang ZL,Sabin CA,Dong BQ,Wei SC,Chen QY,Fang KX, Yang JY,Huang J,Wang XY,Harrison TJ. Hepatitis B virus pre-S deletion mutations are a risk factor for hepatocellular carcinoma: a matched nested case-control study. J Gen Virol 2008; 89: 2882-2890.
  • 8Wang HC,Chang WT,Chang WW,Wu HC,Huang W,Lei HY,Lai MD,Fausto N,Su IJ. Hepatitis B virus pre-S2 mutant upregulates cyclin A expression and induces nodular proliferation of hepatocytes. Hepatology 2005; 41: 761-770.
  • 9Park IY,Sohn BH,Yu E,Suh DJ,Chung YH,Lee JH,Surzycki SJ,Lee YI. Aberrant epigenetic modifications in hepatocarcinogenesis induced by hepatitis B virus X protein. Gastroenterology 2007; 132: 1476-1494.
  • 10Su H,Zhao J,Xiong Y,Xu T,Zhou F,Yuan Y,Zhang Y,Zhuang SM. Large-scale analysis of the genetic and epigenetic alterations in hepatocellular carcinoma from Southeast China. Mutat Res 2008; 641: 27-35.

共引文献24

同被引文献9

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部